$13.77
-0.46-3.23%
At close: -
$14.25
0.483.49%
After Hours: 9:19 AM EDT
Comments
Loading...
NeuroPace (NPCE) Forecast
NewsEarningsNeuroPace (NPCE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestNeuroPace (NASDAQ:NPCE) Stock Quotes, Forecast and News Summary
NeuroPace Stock (NASDAQ: NPCE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy NeuroPace (NPCE) stock?
You can purchase shares of NeuroPace (NASDAQ:NPCE) through any online brokerage.
Who are NeuroPace (NPCE) competitors?
Other companies in NeuroPace’s space includes: CeriBell (NASDAQ:CBLL), Axogen (NASDAQ:AXGN), SI-BONE (NASDAQ:SIBN), Semler Scientific (NASDAQ:SMLR) and Baird Medical Investment (NASDAQ:BDMD).
What is the forecast, or price target, for NeuroPace (NPCE) stock?
NeuroPace has a consensus price target of $15.09.
What is the current price for NeuroPace (NPCE)?
The stock price for NeuroPace (NASDAQ: NPCE) is $14.25 last updated February 21, 2025 at 9:19 AM EST.
Does NeuroPace (NPCE) pay a dividend?
There are no upcoming dividends for NeuroPace.
When is NeuroPace (NASDAQ:NPCE) reporting earnings?
NeuroPace’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is NeuroPace (NPCE) going to split?
There is no upcoming split for NeuroPace.
What sector and industry does NeuroPace (NPCE) operate in?
NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.